ALL |
Acute Lymphocytic Leukemia |
AML |
Acute Myeloid Leukemia |
Bcl2 |
B Cell Lymphoma 2 |
BCR-ABL |
Breakpoint Cluster Region - Abelson |
BM |
Bone Marrow |
BMMSC |
Bone Marrow-Derived Mesenchymal Stem Cell |
BMSC |
Bone Marrow Stromal Cell |
CAR |
C-X-C Motif Chemokine Ligand-12-abundant reticular |
CBX |
Carbenoxolone |
CLL |
Chronic Lymphocytic Leukemia |
CML |
Chronic Myeloid Leukemia |
CNS |
Central Nervous System |
CTLA-4 |
Cytotoxic T Lymphocyte-associated Antigen 4 |
Cx |
Connexin |
CXCL2 |
C-X-C Motif Chemokine Ligand 2 |
CXCL12 |
C-X-C Motif Chemokine Ligand-12 |
DKK-1 |
Dickkopf-1 |
EC |
Endothelial Cell |
EV |
Extracellular Vesicle |
HEV |
High Endothelial Venule |
HIF |
Hypoxia Inducible Factor |
HSC |
Hematopoietic Stem Cell |
HSCT |
Hematopoietic Stem Cell Transplantation |
HSPC |
Hematopoietic stem and Progenitor Cell |
HUVEC |
Human Umbilical Vein Endothelial Cell |
ICAM-1 |
Intercellular Adhesion Molecule-1 |
IL-8 |
Interleukin-8 |
IL-15 |
Interleukin-15 |
IL-15Rα |
Interleukin-15 Receptor Alpha |
K3 |
Kindlin-3 |
LFA-1 |
Lymphocyte Function-associated Antigen-1 |
IGF1 |
Insulin-Like Growth Factor-1 |
LSC |
Leukemic Stem Cell |
LT-HSC |
Long-Term Hematopoietic Stem Cell |
MHC |
Major Histocompatibility Complex |
MRD |
Minimal Residual Disease |
MSC |
Mesenchymal Stem Cell |
MAdCAM-1 |
Mucosal Addressin Cell Adhesion Molecule-1 |
miR |
Micro RNA |
mTOR |
Mammalian Target of Rapamycin |
NK |
Natural Killer |
NKGD2 |
Natural Killer Group 2, Member D |
NKX2-3 |
NK2 Homeobox 3 |
Ph+ |
Philadelphia Chromosome-Positive |
ROS |
Reactive Oxygen Species |
RUNX |
Runt-related Transcription Factor |
STC1 |
Stanniocalcin 1 |
TGF-β1 |
Transforming Growth Factor–beta 1 |
TKI |
Tyrosine Kinase Inhibitor |
TNF |
Tumor Necrosis Factor |
VCAM-1 |
Vascular Cell Adhesion Molecule-1 |
VEGF-AA |
Vascular Endothelial Growth Factor A-A |
VLA-4 |
Very Late Antigen-4 |
WHO |
World Health Organization |